Symptomatic parvovirus B19 infection caused by blood component transfusion.
about
Human Parvovirus B19 and blood product safety: a tale of twenty years of improvementsSerological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units.Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.Alternative blood products and clinical needs in transfusion medicineParvovirus B19V DNA contamination in Chinese plasma and plasma derivativesParvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet ConcentrateParvovirus b19 infections and blood counts in blood donors.Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran.Improving appropriateness of blood utilization through prospective review of requests for blood products: the role of pathology residents as consultants.Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.Human Parvoviruses.The prevalence of hepatitis A virus and parvovirus B19 in source-plasma donors and whole blood donors in China.The genomic and seroprevalence of human bocavirus in healthy Chinese plasma donors and plasma derivatives.Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress.A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?B19: benign or not?Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels.Parvovirus B19: What Is the Relevance in Transfusion Medicine?Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.Pathogens transmitted in red blood cell transfusions: An up-to-date table.
P2860
Q28087734-1381E0A6-9224-43E3-9F6A-031AB1ED00A9Q35174034-C55CC339-E7C2-4DED-ACCF-BD9A02951FC8Q35185105-5D4FB224-864F-4B7D-A027-51C1C3F29AC5Q35915095-4C598AC6-72F4-41D4-BBA2-F65246805C98Q36448471-61E2C07F-E0DB-4204-936A-D465280440AEQ37045818-BCD4DD71-27EF-4CFE-B1BC-1BED6D7C6356Q37630327-B92FFFA6-4F87-4AF2-8FCA-48811BF443DBQ37740416-CFE35CB5-C4DC-4F35-8BC1-9258A1BA54E8Q38232683-9B689FA4-12FB-45F4-9279-833826D15353Q38385954-22BCE2F0-F580-48D8-9BB3-83AF2B2B6F8AQ38996997-F4C35CA0-7C93-4B2F-970F-F8FA3051E263Q40911538-D231F6F9-AD09-444F-9434-0B84AA826452Q42204512-E7DF7357-36CC-4B31-AF23-17F3805C00D6Q42251927-77122C7A-0BC1-4712-923C-2104A0A573C2Q42258587-740EDCB0-53C8-40C5-BF72-1421170743CAQ43146818-CBFE7CCE-311F-47B7-AF0B-2C96F432D37CQ43494599-A51DC4A8-D0E4-499F-BAFE-3231C98B62E3Q45357632-1FBC3559-1BB8-46AC-93EA-01282E250067Q47147160-7EFFCE74-6143-434A-B5A2-24D598264A48Q47830053-88EEE49F-F3C1-4335-AA09-ED9AE81DD644Q49416500-7461223D-30F9-4D52-952E-B27DFF72D2A1Q50500602-9DD67BE3-D101-456E-AA75-0BCD0534EC11Q55339955-93127727-2458-4ACB-A946-9B6D1A5F3CBB
P2860
Symptomatic parvovirus B19 infection caused by blood component transfusion.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Symptomatic parvovirus B19 infection caused by blood component transfusion.
@en
Symptomatic parvovirus B19 infection caused by blood component transfusion.
@nl
type
label
Symptomatic parvovirus B19 infection caused by blood component transfusion.
@en
Symptomatic parvovirus B19 infection caused by blood component transfusion.
@nl
prefLabel
Symptomatic parvovirus B19 infection caused by blood component transfusion.
@en
Symptomatic parvovirus B19 infection caused by blood component transfusion.
@nl
P2093
P2860
P1433
P1476
Symptomatic parvovirus B19 infection caused by blood component transfusion.
@en
P2093
Kenji Tadokoro
Masahiro Satake
Rikizo Taira
Satoru Hino
Shun-ya Momose
Yuji Hoshi
P2860
P304
P356
10.1111/J.1537-2995.2010.03047.X
P577
2011-02-18T00:00:00Z